The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology.
about
Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype.Development and validation of a mortality risk model for pediatric sepsis.Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis.Interleukin-10 rs2227307 and CXCR2 rs1126579 polymorphisms modulate the predisposition to septic shock.Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock Biology.Cytokine Profiles during Invasive Nontyphoidal Salmonella Disease Predict Outcome in African Children.Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatmentInnovation in Pediatric Cardiac Intensive Care: An Exponential Convergence Toward Transformation of Care.Incorporating Inflammation into Mortality Risk in Pediatric Acute Respiratory Distress Syndrome.Sepsis in Pediatric Cardiac Intensive Care.Monitoring Severity of Multiple Organ Dysfunction Syndrome: New Technologies.Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP.Comparing the prognostic performance of ASSIST to interleukin-6 and procalcitonin in patients with severe sepsis or septic shock.Procalcitonin and Pancreatic Stone Protein Function as Biomarkers in Early Diagnosis of Pediatric Acute Osteomyelitis.An Enrichment Strategy For Sepsis Clinical Trials.
P2860
Q33434503-F5BEF985-7B6D-4818-BED7-2769AC98E633Q33714429-91258D2F-F784-48CF-92F5-B7F904BCF8ACQ34490041-CCBB0198-90C9-4510-8984-7E7814E85577Q35849269-046E530A-21A3-488D-8D4F-328F108117DAQ36437648-807D0948-4544-4604-A8B5-2F6C210B9AE1Q37067282-B056AFA9-8F4D-44DD-88AF-6B6C7C586FC2Q38241694-BD56D84D-5D12-45EE-B6EA-478487022505Q38607400-C265331F-1B03-4CF1-BA7F-9E4B66522859Q38751954-D9FE9B27-F7DE-4067-A7B4-E95A80ECFCA5Q38834618-3DFA1975-279D-43B1-8E68-924D21D85346Q38935727-1754FF56-8AE3-48DA-A1BE-93058C80BD58Q40285651-63062907-CC17-4899-AF1C-F1E231073C1BQ41551089-8A699ED4-B565-4744-8157-3BB5680E1B75Q47161819-95DAD5D3-383C-412F-AD3B-A384AE106813Q49160004-4177FD03-A96B-48D4-97ED-FAB72BD6A34B
P2860
The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The pediatric sepsis biomarker ...... or sepsis therapy and biology.
@ast
The pediatric sepsis biomarker ...... or sepsis therapy and biology.
@en
type
label
The pediatric sepsis biomarker ...... or sepsis therapy and biology.
@ast
The pediatric sepsis biomarker ...... or sepsis therapy and biology.
@en
prefLabel
The pediatric sepsis biomarker ...... or sepsis therapy and biology.
@ast
The pediatric sepsis biomarker ...... or sepsis therapy and biology.
@en
P2860
P1476
The pediatric sepsis biomarker ...... for sepsis therapy and biology
@en
P2093
Christopher J Lindsell
P2860
P304
P356
10.1586/14787210.2014.912131
P577
2014-04-22T00:00:00Z